Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$4.8 - $7.24 $170,376 - $256,983
35,495 Added 10.29%
380,492 $107,000
Q3 2021

Nov 12, 2021

BUY
$13.8 - $20.6 $152,793 - $228,083
11,072 Added 3.32%
344,997 $237,000
Q2 2021

Aug 13, 2021

BUY
$17.92 - $27.8 $2.23 Million - $3.46 Million
124,458 Added 59.42%
333,925 $347,000
Q2 2020

Aug 13, 2020

BUY
$12.18 - $29.0 $108,255 - $257,752
8,888 Added 4.43%
209,467 $274,000
Q4 2019

Feb 13, 2020

BUY
$29.6 - $49.4 $88,119 - $147,063
2,977 Added 1.51%
200,579 $459,000
Q3 2019

Nov 12, 2019

BUY
$39.2 - $63.2 $1.97 Million - $3.18 Million
50,332 Added 34.18%
197,602 $391,000
Q2 2019

Aug 14, 2019

BUY
$60.4 - $84.2 $8.9 Million - $12.4 Million
147,270 New
147,270 $446,000

About Motus GI Holdings, Inc.


  • Ticker MOTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,996,840
  • Description
  • Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
More about MOTS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.